1117 related articles for article (PubMed ID: 17852878)
21. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.
Bazzigaluppi E; Roggero P; Parma B; Brambillasca MF; Meroni F; Mora S; Bosi E; Barera G
Dig Liver Dis; 2006 Feb; 38(2):98-102. PubMed ID: 16386476
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease].
Matusiewicz K; Iwańczak B; Matusiewicz M; Iwańczak F
Pol Merkur Lekarski; 2006 Jan; 20(115):17-21. PubMed ID: 16617728
[TBL] [Abstract][Full Text] [Related]
23. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
[TBL] [Abstract][Full Text] [Related]
24. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.
Rashtak S; Ettore MW; Homburger HA; Murray JA
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):426-32; quiz 370. PubMed ID: 18304884
[TBL] [Abstract][Full Text] [Related]
25. Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study.
Kappler M; Krauss-Etschmann S; Diehl V; Zeilhofer H; Koletzko S
BMJ; 2006 Jan; 332(7535):213-4. PubMed ID: 16377644
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
[TBL] [Abstract][Full Text] [Related]
27. No induction of anti-avenin IgA by oats in adult, diet-treated coeliac disease.
Guttormsen V; Løvik A; Bye A; Bratlie J; Mørkrid L; Lundin KE
Scand J Gastroenterol; 2008; 43(2):161-5. PubMed ID: 18224563
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease.
Lewis NR; Scott BB
Aliment Pharmacol Ther; 2010 Jan; 31(1):73-81. PubMed ID: 19664074
[TBL] [Abstract][Full Text] [Related]
29. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease.
Prause C; Ritter M; Probst C; Daehnrich C; Schlumberger W; Komorowski L; Lieske R; Richter T; Hauer AC; Stern M; Uhlig HH; Laass MW; Zimmer KP; Mothes T
J Pediatr Gastroenterol Nutr; 2009 Jul; 49(1):52-8. PubMed ID: 19465869
[TBL] [Abstract][Full Text] [Related]
30. Tissue transglutaminase antibodies in celiac disease: assessment of a commercial kit.
Sugai E; Selvaggio G; Vazquez H; Viola M; Mazure R; Pizarro B; Smecuol E; Flores D; Pedreira S; Mauriño E; Gomez JC; Bai JC
Am J Gastroenterol; 2000 Sep; 95(9):2318-22. PubMed ID: 11007235
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase.
Dahle C; Hagman A; Ignatova S; Ström M
Aliment Pharmacol Ther; 2010 Jul; 32(2):254-60. PubMed ID: 20456302
[TBL] [Abstract][Full Text] [Related]
32. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
Liu E; Li M; Emery L; Taki I; Barriga K; Tiberti C; Eisenbarth GS; Rewers MJ; Hoffenberg EJ
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):293-300. PubMed ID: 17873740
[TBL] [Abstract][Full Text] [Related]
33. Comparison of commercially available serologic kits for the detection of celiac disease.
Naiyer AJ; Hernandez L; Ciaccio EJ; Papadakis K; Manavalan JS; Bhagat G; Green PH
J Clin Gastroenterol; 2009 Mar; 43(3):225-32. PubMed ID: 18724250
[TBL] [Abstract][Full Text] [Related]
34. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.
Hopper AD; Hadjivassiliou M; Hurlstone DP; Lobo AJ; McAlindon ME; Egner W; Wild G; Sanders DS
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):314-20. PubMed ID: 18328437
[TBL] [Abstract][Full Text] [Related]
35. New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deamidated gliadin.
Prause C; Richter T; Koletzko S; Uhlig HH; Hauer AC; Stern M; Zimmer KP; Laass MW; Probst C; Schlumberger W; Mothes T
Ann N Y Acad Sci; 2009 Sep; 1173():28-35. PubMed ID: 19758128
[TBL] [Abstract][Full Text] [Related]
36. Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
Földes-Papp Z; Demel U; Berry D; Domej W; Fuchs D; Tilz GP
J Immunoassay Immunochem; 2002; 23(2):211-27. PubMed ID: 12033644
[TBL] [Abstract][Full Text] [Related]
37. Atypical coeliac disease found with serologic screening.
Collin P; Hällström O; Mäki M; Viander M; Keyriläinen O
Scand J Gastroenterol; 1990 Mar; 25(3):245-50. PubMed ID: 2320942
[TBL] [Abstract][Full Text] [Related]
38. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
[TBL] [Abstract][Full Text] [Related]
39. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
40. Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.
Devery JM; La Brooy JT; Krillis S; Davidson G; Skerritt JH
Clin Exp Immunol; 1989 Jun; 76(3):384-90. PubMed ID: 2752594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
